Show simple item record

dc.contributor.authorCornberg, Markus
dc.contributor.authorLok, Anna Suk-Fong
dc.contributor.authorTerrault, Norah A
dc.contributor.authorZoulim, Fabien
dc.date.accessioned2022-06-13T09:13:18Z
dc.date.available2022-06-13T09:13:18Z
dc.date.issued2020-03
dc.date.submitted2019-07-10
dc.identifier.pmid31730789
dc.identifier.doi10.1016/j.jhep.2019.11.003
dc.identifier.urihttp://hdl.handle.net/10033/623205
dc.language.isoenen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectAntiviral therapyen_US
dc.subjectCpAMen_US
dc.subjectHepatitis B surface antigenen_US
dc.subjectHepatitis Den_US
dc.subjectImmunomodulatory therapyen_US
dc.subjectNucleos(t)ide analoguesen_US
dc.titleGuidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference.en_US
dc.typeArticleen_US
dc.typeOtheren_US
dc.identifier.eissn1600-0641
dc.identifier.journalJournal of hepatologyen_US
dc.source.volume72
dc.source.issue3
dc.source.beginpage539
dc.source.endpage557
refterms.dateFOA2022-06-13T09:13:19Z
dc.source.journaltitleJournal of hepatology
dc.source.countryUnited Kingdom
dc.source.countryNetherlands


Files in this item

Thumbnail
Name:
Publisher version
Thumbnail
Name:
CornbergHepatology2020.pdf
Size:
327.2Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's license is described as Attribution 4.0 International